⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for bcl2

Every month we try and update this database with for bcl2 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLNCT03740529
Chronic Lymphoc...
Waldenstrom Mac...
Mantle Cell Lym...
Marginal Zone L...
B-cell Lymphoma
Small Lymphocyt...
Pirtobrutinib
Venetoclax
Rituximab
18 Years - Eli Lilly and Company
ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell LymphomaNCT00169130
Lymphoma, Large...
doxorubicin
cyclophosphamid...
Autologous stem...
18 Years - 60 YearsLymphoma Study Association
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHLNCT03740529
Chronic Lymphoc...
Waldenstrom Mac...
Mantle Cell Lym...
Marginal Zone L...
B-cell Lymphoma
Small Lymphocyt...
Pirtobrutinib
Venetoclax
Rituximab
18 Years - Eli Lilly and Company
A Study of CG-806 in Patients With Relapsed or Refractory AML or Higher-Risk MDSNCT04477291
Acute Myeloid L...
Myelodysplastic...
CG-806
18 Years - Aptose Biosciences Inc.
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: